We would love to hear your thoughts about our site and services, please take our survey here.
10 Aug RNS “The recent developments meet key milestones to begin commercial clinical trials. The Company is now engaged in clinical trials design to support the validation and accreditation of the CIZ1B test prior to commercial launch”.
So, between then and recent RNS some critical information has been held back / failed to notify the Market as we are now not ready for Critical Trials / although Allan in Directors Talk states this is a formality / inferring it’s a slam dunk (Correct me if I’m wrong I can go back to the minutes and seconds if necessary.
Allan has also failed to explain the reason for change in direction re the Finance and this has had a clear effect on the SP.
He’s states we have”New Shareholders” re this change of Financing so why would they Invest anything unless they knew more than the RNS ?
All in all there is more than a sniff of suspicion that Allan continues to withhold information that would no doubt have a material effect on SP if he notified Market. Positive or Negative / remains to be seen. Proof already registered as Negative to SP re intension to change Finance structure.
Apologies if this merely Repeats what has been said / I am just catching up and using this as a Marker to refer back to.
Why has Allan switched to Novum securities when he hasn’t drawn down any (Any ?? Zero ??) of the £500k fund.
The answer must be that whoever behind the vehicle - Novum / has promised more funding down the line should it be required. So prepare for 2p super low price access until Cizz get to production ?
They only raise enough to keep going 6 month … Don’t they ??
Really disappointed Allan didn’t RNS where Cizzle fits into the Cancer battle / structure of things after the BBC specifically named Lung Cancer breakthrough yesterday. However ; it seemed to me that the “Breakthrough” was ability in detecting Defecting genes once the Tumor was present / so hopefully our goal is to identify much earlier than that - but would be ideal opportunity for Allan to inform his Shareholders where we fit in the grand scheme. Radio silence continueth.
As prev stated. I doubt they will make the £100 Target due to recent Global Inflation. However ; the overriding goal is clearly to deliver a low cost price so that maximum tests can be utilised and thus eradicate Lung to a minimum. The only way to do this is to catch it early and continue regular testing to those at risk.
“Lung cancer is often curable if caught while still contained in your lung. Lung cancer that has spread beyond your lung isn't usually considered curable. The American Cancer Society estimates that there were approximately 236,740 new lung cancer cases in the United States in 2022. Jan 2023”.
And good of you to offer detailed opinion Greend100. This is what a bb is all about. Helps us adjust our own ideas and corroborate and come to some sort of consensus which is hopefully more accurate than when we first spoke.
Agree with Oak that Cizzle quoted £100/Test and this was against a competitor with much less Accuracy (Although our Accuracy is not yet corroborated). However / Since then we have had Global inflation. So I would say very unlikely to meet that £100 Target.
I find it bizarre how Allan states “and other Cancers”. Comes across as if “Other Cancers” is just a sideshow. It’s MASSIVE if they can apply the mechanics of Ciz1b Test to other Cancers inc Breast. So I think this has a lot of potential. Hey / They’ve started with the Highest death rate in Lung Cancer.
Should Allan ever name and be more specific on the “Other Cancers” then that would be tremendous in terms of potential.
No RNS for coming up to 6 Months..
It’s typical of the MM’s not allowing a Free Quote beyond 150.000 shares. Only 1 Trade over 150.000 since 9:45am this morning. It’s hardly a Free flowing Market is ? It will certainly Flow free if they can give good news on Working Capital / coupled with a production start date. Don’t want to say too much beyond that.
Whoever Buying and Selling / to me it looks like they are Accumulating. It took a Net 2 million to go from 2 to 2.5. Someone with Level 2 would be well served Noting every trade over 2.5 to see what Net is required to take it to 2.75 and then to 3. No need for excitement yet as Allan has not laid out Working Capital position. Either way if it’s 2 million Net to move this every 0.5 / then that’s absolutely very little. GLA. LT holder here until the end.